Skip to main content

Beneficial ownership — 13D / 13G

87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
BlackRock Inc. AAXJ iShares Trust 13G/A 4.4% 2y
BlackRock Inc. BGC BGC Group, Inc. 13G/A 12.3% 2y
BlackRock Inc. AAXJ iShares Trust 13G/A 7.1% 2y
BlackRock Inc. BAI BlackRock ETF Trust 13G/A 71.7% 2y
BlackRock Inc. AAXJ iShares Trust 13G/A 25% 2y
BlackRock Inc. SCPH scPharmaceuticals Inc. Common Stock 13G/A 4.99% 2y
BlackRock Inc. BAI BlackRock ETF Trust 13G/A 44.4% 2y
BlackRock Inc. STR Sitio Royalties Corp. 13G/A 3.9% 2y
First Trust Capital Management L.P. ZPTA Zapata Quantum, Inc. 13G/A 0% 2y
BlackRock Inc. ARKO ARKO Corp. 13G/A 4.9% 2y
BlackRock Inc. DX Dynex Capital Inc 13G/A 10.3% 2y
BlackRock Inc. AAXJ iShares Trust 13G/A 25% 2y
BlackRock Inc. OIS Oil States International, Inc 13G/A 11% 2y
BlackRock Inc. PR Permian Resources Corp 13G/A 10.6% 2y
BlackRock Inc. BCLO BlackRock ETF Trust II 13G/A 64.2% 2y
BlackRock Inc. AAXJ iShares Trust 13G/A 30.4% 2y
BlackRock Inc. LEGN Legend Biotech Corp 13G/A 3% 2y
BlackRock Inc. CPE Callon Petroleum Company 13G/A 1% 2y
BlackRock Inc. NLOP Net Lease Office Properties 13G/A 4.7% 2y
BlackRock Inc. WKHS Workhorse Group Inc. 13G/A 4.99% 2y
BlackRock Inc. AAXJ iShares Trust 13G/A 3.7% 2y
BlackRock Inc. CXM Sprinklr, Inc. 13G/A 10.7% 2y
BlackRock Inc. W Wayfair Inc. 13G/A 5% 2y
BlackRock Inc. VICI Vici Properties Inc. 13G/A 10% 2y
BlackRock Inc. LAMR Lamar Advertising Co 13G/A 10.3% 2y
BlackRock Inc. BAI BlackRock ETF Trust 13G 100% 2y
BlackRock Inc. ENOV Enovis CORP 13G/A 10.5% 2y
BlackRock Inc. WHR Whirlpool Corp 13G/A 11.4% 2y
WELLINGTON MANAGEMENT GROUP LLP SQSP Squarespace, Inc. 13G/A 11.03% 2y
Archon Capital Management LLC APYX Apyx Medical Corp 13D 9.96% 2y
WELLINGTON MANAGEMENT GROUP LLP RCKT Rocket Pharmaceuticals, Inc. 13G/A 10.12% 2y
WELLINGTON MANAGEMENT GROUP LLP HASI HA Sustainable Infrastructure Capital, Inc. 13G/A 10.2% 2y
GATES FOUNDATION TRUST TDF Templeton Dragon Fund Inc 13G 5.1% 2y
Hancock Prospecting Pty Ltd MP MP Materials Corp. 13G 5.3% 2y
Prelude Fund, LP ZPTA Zapata Quantum, Inc. 13G 8% 2y
Rock Springs Capital Management LP XLO Xilio Therapeutics, Inc. 13G/A 8.71% 2y
Deep Track Capital, LP AVTX Avalo Therapeutics, Inc. 13G 9.99% 2y
GILEAD SCIENCES, INC. XLO Xilio Therapeutics, Inc. 13G 19.9% 2y
Global Coretech Growth Fund 1 GCTS GCT Semiconductor Holding, Inc. 13G 5.12% 2y
Ole Nielsen TRUP Trupanion, Inc. 13G/A 6.9% 2y
ADAR1 Partners, LP IBIO iBio, Inc. 13G 9.27% 2y
Phillip Frost, M.D. BCDA BioCardia, Inc. 13D/A 4.8% 2y
Jonathan Honig GVP GSE Systems, Inc. 13G 5.96% 2y
Yehuda Nir PYPD PolyPid Ltd. 13G 17.6% 2y
Western Standard LLC ORKA Oruka Therapeutics, Inc. 13G/A 9.8% 2y
First Trust Capital Management L.P. ISRLF Israel Acquisitions Corp 13G/A 11.88% 2y
SIT INVESTMENT ASSOCIATES INC VBF Invesco Bond Fund 13G 6.48% 2y
SIT INVESTMENT ASSOCIATES INC HIX Western Asset High Income Fund II Inc. 13G 10.46% 2y
SIT INVESTMENT ASSOCIATES INC FTF Franklin Ltd Duration Income Trust 13G/A 4.79% 2y
SIT INVESTMENT ASSOCIATES INC FINS Angel Oak Financial Strategies Income Term Trust 13G 9.25% 2y